Null association between androgen-deprivation therapy and nonprostate cancer mortality among older men with nonmetastatic prostate cancer
Urologic Oncology: Seminars and Original Investigations Mar 07, 2018
Wallis CJD, et al. - In patients with non-metastatic prostate cancer, the impact of androgen-deprivation therapy (ADT) on non-prostate cancer mortality was assessed. In a cohort of older men with localized prostate cancer treated with surgery or radiation therapy, ADT was not shown to be related to non-prostate cancer or cardiovascular mortality.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
